Staff turnover in EUR290,778233,982339,463246,205160,841
Staff turnover in EUR290,778233,982339,463246,205160,841
The share: stated in EUR20212022202320242025
Shares outstanding (in mn.)56.7263.8163.816.086.08
Dividend per share-----
Basic earnings per share8.05-9.39-0.12-0.72-0.65
P/L in EUR million under IAS/IFRS20212022202320242025
Turnover28.825.732.221.713.2
Operating income (EBIT)24.71.15.1-6.8-1.2
Earnings before taxes21.01.05.1-6.7-1.2
Annual net profit/ loss38.3-44.2-0.4-4.4-6.9
Balance sheet in EUR million under IAS/IFRS20212022202320242025
Assets
Total current assets14.415.117.716.313.9
Total fixed assets62.918.313.513.96.8
Total assets77.233.431.330.220.7
Liabilities
Total short-term liabilities17.58.410.110.55.7
Total long-term liabilities1.84.61.20.80.1
Total provisions0.00.00.00.00.0
Equity capital58.020.320.018.914.9
Total liabilities77.233.431.330.220.7
Management:
Pilar de la Huerta
Board:
Helge Lubenow
Alexander Link
Heikki Lanckriet
Hansjörg Plaggemars
Karlheinz Schmelig
Tobias Reich
Shareholding in %:
Address: Hemmelrather Weg 201, 51377 Leverkusen
T: +49-214-87-63-2-0
F: +49-214-87-63-2-90
I: http://biofrontera.com
E: [email protected]